S. Vanichseni

发表

Risk factors and HIV seropositivity among injecting drug users in Bangkok.

D. D. Des Jarlais, S. Friedman, M. Carballo, 1991, AIDS.

Blood and Seminal Plasma HIV-1 RNA Levels Among HIV-1-Infected Injecting Drug Users Participating in the AIDSVAX B/E Efficacy Trial in Bangkok, Thailand

P. Gilbert, J. Tappero, J. Mcnicholl, 2009, Journal of acquired immune deficiency syndromes.

Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United. States

D. D. Des Jarlais, S. Friedman, S. Friedman, 1993, AIDS.

International epidemiology of HIV and AIDS among injecting drug users.

S. Friedman, D. D. des Jarlais, D. C. Jarlais, 1992, AIDS.

AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok.

S. Friedman, D. D. des Jarlais, D C Des Jarlais, 1994, American journal of public health.

The Thai HIV/AIDS epidemic at 15 years: sustained needle sharing among southern Thai drug injectors.

D. Celentano, Pajongsil Perngmark, S. Vanichseni, 2008, Drug and alcohol dependence.

HIV among injecting drug users in Bangkok: the first decade

T. Mastro, D. C. Jarlais, P. Mock, 2002 .

AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization.

P. Pitisuttithum, J. Kaewkungwal, D. Francis, 2000, AIDS research and human retroviruses.

High HIV Seroprevalence Epidemics among Injecting Drug Users; New York City and Bangkok

D. D. Des Jarlais, S. Friedman, P. Friedmann, 1997 .

HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.

J. Tappero, R. Byers, F. van Griensven, 2003, AIDS research and human retroviruses.

Cross-reactive T cell responses in HIV CRF01_AE and B'-infected intravenous drug users: implications for superinfection and vaccines.

J. Mcnicholl, D. Hu, C. Thielen, 2009, AIDS research and human retroviruses.

Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions

C. Celum, K. Page, L. Maher, 2015, Journal of acquired immune deficiency syndromes.

CDC international HIV prevention research activities among injection drug users in Thailand and Russia

J. Tappero, A. Greenberg, S. Santibañez, 2005, Journal of Urban Health.

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

J. Tappero, P. Pitisuttithum, D. Francis, 2004, AIDS.

Determination of HIV‐1 subtypes in injecting drug users in Bangkok, Thailand, using peptide‐binding enzyme immunoassay, and heteroduplex mobility assay: evidence of increasing infection with HIV‐1 subtype E

J. Mullins, C. Luo, E. Delwart, 1995, AIDS.

Estimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method.

T. Mastro, K. Limpakarnjanarat, B. Weniger, 1994, American journal of public health.

"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.

D. D. Des Jarlais, H. Wolfe, T. Mastro, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Was the 1988 HIV epidemic among Bangkok's injecting drug users a common source outbreak?

P. Akarasewi, K. Choopanya, S. Vanichseni, 1994, AIDS.

Altered Antibody Responses in Persons Infected with HIV-1 While Using Preexposure Prophylaxis

J. Mcnicholl, K. Curtis, W. Leelawiwat, 2021 .

A controlled trial of methadone maintenance in a population of intravenous drug users in Bangkok: implications for prevention of HIV.

K. Choopanya, S. Vanichseni, B. Wongsuwan, 1991, The International journal of the addictions.

Higher viral loads and other risk factors associated with HIV-1 seroconversion during a period of high incidence among injection drug users in Bangkok.

D. D. Des Jarlais, R. Byers, F. van Griensven, 2002, Journal of acquired immune deficiency syndromes.

The Spread of HIV-1 Subtypes B and CRF01_AE Among Injecting Drug Users in Bangkok, Thailand

J. Tappero, F. van Griensven, W. Kittikraisak, 2007, Journal of acquired immune deficiency syndromes.

HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995–2012

J. Tappero, P. Pitisuttithum, J. Kaewkungwal, 2019, EClinicalMedicine.

The recent epidemiology of HIV and AIDS in Thailand.

T. Brown, W. Sittitrai, U. Thisyakorn, 1994, AIDS.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

C. Hendrix, J. Mcnicholl, R. Chuachoowong, 2013, The Lancet.

Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand

J. Esparza, T. Mastro, W. Heyward, 2001, AIDS.

Sexual Risk Reduction in a Cohort of Injecting Drug Users in Bangkok, Thailand

D. D. Des Jarlais, J. Tappero, F. van Griensven, 2003, Journal of acquired immune deficiency syndromes.

HIV Risk Reduction in a Cohort of Injecting Drug Users in Bangkok, Thailand

D. D. Des Jarlais, J. Tappero, F. van Griensven, 2003, Journal of acquired immune deficiency syndromes.

Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

R. Byers, T. Mastro, Bharat S Parekh, 2002, AIDS research and human retroviruses.

Intersubtype Human Immunodeficiency Virus Type 1 Superinfection following Seroconversion to Primary Infection in Two Injection Drug Users

J. Mcnicholl, T. Mastro, T. Folks, 2002, Journal of Virology.

Renal function of participants in the Bangkok tenofovir study--Thailand, 2005-2012.

J. Mcnicholl, M. Curlin, W. Leelawiwat, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes

Reshma Kassanjee, Alex Welte, John Nkengasong, 2015, PloS one.

Incarceration and Risk for HIV Infection Among Injection Drug Users in Bangkok

D. D. Des Jarlais, T. Mastro, W. Heyward, 2002, Journal of acquired immune deficiency syndromes.

Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand.

D. D. Des Jarlais, J. Esparza, T. Mastro, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Risk Behaviors and Risk Factors for HIV Infection among Participants in the Bangkok Tenofovir Study, an HIV Pre-Exposure Prophylaxis Trial among People Who Inject Drugs

J. Mcnicholl, M. Curlin, L. Paxton, 2014, PloS one.

Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.

J. Tappero, P. Pitisuttithum, F. van Griensven, 2009, Addiction.

Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand

J. Mcnicholl, F. van Griensven, R. Chuachoowong, 2011, PloS one.

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand

J. Tappero, P. Pitisuttithum, F. van Griensven, 2004, AIDS.

Frequent Human Leukocyte Antigen Class I Alleles Are Associated With Higher Viral Load Among HIV Type 1 Seroconverters in Thailand

T. Hodge, J. Tappero, J. Mcnicholl, 2004, Journal of acquired immune deficiency syndromes.

Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand.

T. Mastro, N. Young, D. Hu, 2000, AIDS research and human retroviruses.

HIV-1 genetic diversity to estimate time of infection and infer adherence to pre-exposure prophylaxis.

W. Heneine, J. Mcnicholl, M. Curlin, 2019, AIDS.

Altered Antibody Responses in Persons Infected with HIV-1 While Using PrEP.

J. Mcnicholl, K. Curtis, W. Leelawiwat, 2020, AIDS research and human retroviruses.

Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand.

R. Janssen, R. Byers, T. Mastro, 2003, AIDS research and human retroviruses.

The epidemiology of HIV infection and AIDS in Thailand.

K. Ungchusak, P. Thongcharoen, K. Limpakarnjanarat, 1991, AIDS.

The evolving molecular epidemiology of HIV‐1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials

J. Mullins, C. Luo, E. Delwart, 1995, AIDS.

High Mortality Among Non-HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005-2012.

J. Mcnicholl, M. Curlin, L. Paxton, 2015, American journal of public health.

HighMortalityAmongNon-HIV-InfectedPeopleWho InjectDrugsinBangkok,Thailand,2005-2012

J. Mcnicholl, M. Curlin, L. Paxton, 2015 .

Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand.

M. Hudgens, G. Satten, M. Halloran, 2002, American journal of epidemiology.

CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users

J. Tappero, R. Lal, Chunfu Yang, 2004, AIDS.

Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.

T. Holtz, J. Mcnicholl, M. Curlin, 2017, The lancet. HIV.

Hepatitis C virus infection among people who inject drugs in Bangkok, Thailand, 2005–2010

J. Mcnicholl, B. Raengsakulrach, M. Curlin, 2019, WHO South-East Asia journal of public health.

Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin

K. Nelson, L. Solomon, S. Cohn, 1996 .

The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs

J. Mcnicholl, M. Curlin, L. Paxton, 2015, AIDS.

Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.

G. Satten, R. Janssen, T. Mastro, 2001, AIDS research and human retroviruses.

HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study

F. van Griensven, S. Chariyalertsak, N. Phanuphak, 2015, Journal of the International AIDS Society.

HIV Vaccine Trials

D. D. Des Jarlais, M. Marmor, S. Vanichseni, 1998, Science.

New HIV type 1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand.

J. Tappero, T. Mastro, T. Folks, 2003, AIDS research and human retroviruses.

D. D. Des Jarlais, M. Frischer, S. Friedman, 1995, AIDS.

Genetic analysis of incident HIV-1 strains among injection drug users in Bangkok: evidence for multiple transmission clusters during a period of high incidence.

F. van Griensven, T. Mastro, W. Kittikraisak, 2002, Journal of acquired immune deficiency syndromes.

Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand

J. Tappero, T. Mastro, Philip A Mock, 2005, AIDS.

Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.

J. Tappero, P. Pitisuttithum, F. van Griensven, 2010, The International journal on drug policy.

Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis

J. Baeten, D. Glidden, R. Grant, 2022, Pharmaceutics.

HIV antiretroviral prophylaxis for injecting drug users – Authors' reply

P. Mock, Michael Martin, K. Choopanya, 2013, The Lancet.

AIDS beliefs and behaviors among intravenous drug users in Bangkok.

K. Choopanya, S. Vanichseni, N. Wright, 1991, The International journal of the addictions.

Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand

M. Hudgens, M. Halloran, Ira M. Longini Jr, 2001 .

Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand

J. Mcnicholl, M. Curlin, W. Leelawiwat, 2015, PloS one.

Early Markers of HIV-1 Disease Progression in a Prospective Cohort of Seroconverters in Bangkok, Thailand: Implications for Vaccine Trials

K. Buchacz, J. Tappero, J. Kaewkungwal, 2004, Journal of acquired immune deficiency syndromes.

Higher Viral Loads and Other Risk Factors Associated With HIV‐1 Seroconversion During a Period of High Incidence Among Injection Drug Users in Bangkok

D. D. Des Jarlais, R. Byers, F. van Griensven, 2002 .

A comparison of full-length glycoprotein 120 from incident HIV type 1 subtype E and B infections in Bangkok injecting drug users with prototype E and B strains that are components of a candidate vaccine.

T. Mastro, N. Young, D. Hu, 2000, AIDS research and human retroviruses.

Trends in the injection of midazolam and other drugs and needle sharing among injection drug users enrolled in the AIDSVAX B/E HIV-1 vaccine trial in Bangkok, Thailand

J. Tappero, P. Pitisuttithum, F. Griensven, 2005 .

HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand.

D. D. Des Jarlais, S. Friedman, M. Carballo, 1992, Journal of acquired immune deficiency syndromes.

Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand.

J. Tappero, P. Pitisuttithum, D. Francis, 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand.

P Mock, Lillian S. Lin, D. D. Des Jarlais, 1999, Journal of acquired immune deficiency syndromes.

Characterizing HIV-preventive, plasma tenofovir concentrations. A pooled participant-level data analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials.

J. Baeten, D. Glidden, R. Grant, 2022, Clinical Infectious Diseases.

Risk behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial.

S. Vanichseni, S. Migasena, P. Suntharasamai, 1997, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Viral load differences in early infection with two HIV-1 subtypes

W. Heneine, T. Mastro, N. Young, 2001, AIDS.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

C. Hendrix, J. Mcnicholl, R. Chuachoowong, 2013, The Lancet.

HIV vaccine trials [4]

M. Marmor, S. Vanichseni, D. Kitayaporn, 1998 .